Search Close Search
Search Close Search
Page Menu

The Latest News

Alys Launches As Promising New Immuno-Dermatology Company

 

This new venture is co-founded by John Harris, MD, PhD. Dr. Harris, chair and professor of dermatology, director of the Vitiligo Clinic and Research Center, and director of UMCCTS Integrated Biomarkers Core will serve as Chief Innovation Officer at Alys. Alys combines the assets and platforms of six biotechs, including Aldena Therapeutics, a partner of UMass Chan Medical School. See full article here.

Recent Research Funding Awards

 byatt-21m-award-story-s.png

Nancy Byatt, DO, MS’15, MBA, current KL2 Program mentor, former KL2 and Pilot Project Program  awardee continues to shine! A research team led by Dr. Byatt, pictured here with Christopher Sheldrick, PhD, has secured a $21 million award from the Patient-Centered Outcomes Research Institute (PCORI) to conduct a perinatal mental health equity study. Read full story HERE.

 Anderson Wilkins - 2023.png

Pilot Project Program awardee, Melissa Anderson, PhD, associate professor of psychiatry, pictured here with Alexander Wilkins, PhD, assistant professor of psychiatry, are co-directors of the DeafYes! Center for Deaf Empowerment and Recovery at UMass Chan. They have been awarded a $3.6 million award from the National Institute on Alcohol Abuse and Alcoholism to start a nationwide virtual clinic testing evidence-based therapy for Deaf people with trauma symptoms and alcohol use disorders. Read full story HERE.

Research supported by a K23 grant is under way by KL2 scholar Lara Kovell, MD, associate professor, Department of Medicine, Division of Cardiology, on a project titled, “Development of a Mobile Health Intervention for Blood Pressure Management in Pregnancy”.

UMass Chan MD/PhD student Pryce Michener has received an award from the National Institute on Drug Abuse to further his research on substance use and medications for opioid use disorder. Full story HERE.

Congratulations to our New TL1 Postdoc Fellow 

 AAHRPP_Full Accreditation_Logo.png

UMass Chan Medical School awarded

AAHRPP Re-Accreditation

On December 15, 2023, the Council on Accreditation of the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP) once again awarded UMass Chan Medical School Full Accreditation for a period of five years. This is a continuation of the Medical School’s AAHRPP Accreditation, first issued in 2015 and renewed in 2018.

AAHRPP is an independent, nonprofit accrediting body headquartered in Washington, DC which promotes high-quality research through accreditation.  According to AAHRPP, “As the “gold seal,” AAHRPP accreditation offers assurances—to research participants, researchers, sponsors, government regulators, and the general public—that an HRPP is focused first and foremost on excellence.”

For questions and additional information about AAHRPP and UMass Chan, please contact Meg Johnson, JD, CIP at Meg.Johnson@umassmed.edu

Congratulations to our IRB staff who hosted the FDA with only a few days notice and successfully aced the inspection!

Staff Spotlight

Laurel O'Connor, MD, KL2 Scholar  |  Additional details can be found here.

Staff Spotlight

Daniel Amante, PhD, MPH, KL2 Scholar  |  Additional details can be found here.